Skip to main content

Table 1 Patient’s characteristics of the proteome study (n = 47)

From: Proteomic profiling of HBV infected liver biopsies with different fibrotic stages

  

Statistics (N = 47)

Age (mean ± sem)

 

40.98 ± 2.063 (19–66)

Sex

Male

30 (63.8%)

Female

17 (36.2%)

F-score

1

7

2

20

3

12

4

3

5

2

6

3

HAI (mean ± sem)

 

5.36 ± 0.366 (2–11)

logHBVDNA (mean ± sem)

 

6.04 ± 0.263 (1.77–8.94)

AST (mean ± sem)

 

54.59 ± 7.697 (16–309)

ALT (mean ± sem)

 

88.89 ± 14.569 (14–441)

PLT (x103) (mean ± sem)

 

218 ± 8.4 (119–370)

PT (mean ± sem)

 

13.23 ± 0.13 (11.4–16.1)

INR (mean ± sem)

 

1.03 ± 0.0178 (0.85–1.39)

HDL (mean ± sem)

 

46.65 ± 2.29 (27–72)

LDL (mean ± sem)

 

116 ± 5.27 (60–167)

Triglyceride (mean ± sem)

 

105.17 ± 9.59 (36–359)

Glucose (mean ± sem)

 

103.02 ± 6.1 (76–295)

Waist (cm) (mean ± sem)

 

92.48 ± 2.1 (62–120)

BMI (mean ± sem)

 

27 ± 0.7 (19–38)

HBeAg

Positive

11 (23.4%)

Negative

36 (76.6%)

  1. SEM standard error of mean, F fibrosis, HAI hepatic activity index, HBV hepatitis B virus, AST aspartate transaminase, ALT alanine transaminase, PLT platelet, PT prothrombin time, INR international normalized ratio, HDL high density lipoprotein, LDL low density lipoprotein, BMI body mass index, HBeAg hepatitis B early antigen